Literature DB >> 31901817

Bioorthogonal human milk oligosaccharide probes for antimicrobial target identification within Streptococcus agalactiae.

Schuyler A Chambers1, Steven D Townsend2.   

Abstract

Human milk oligosaccharides (HMOs) are a structurally diverse class of carbohydrates that possess strong antibacterial activity against Streptococcus agalactiae (Group B Strep, GBS). This work highlights the design, synthesis, and retained biological activity of several HMO bioorthogonal probes within GBS, a first in class advance. The use of such probes will assist in identifying HMO-protein interactions within GBS and may be broadly applicable in researching HMO cellular targets within a variety of biological systems. Finally, this strategy is highly amenable to other oligosaccharide scaffolds, requiring minimal synthetic transformations and chemical perturbation.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antibacterial activity; Bioorthogonal probes; Group B Streptococcus; Human milk oligosaccharides

Mesh:

Substances:

Year:  2019        PMID: 31901817     DOI: 10.1016/j.carres.2019.107895

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  3 in total

1.  Human Milk Oligosaccharides versus Streptococcus: How a Human-Made Natural Product Protects Us from Pathogens.

Authors:  Laurie M Lyon; Kelly S Doran
Journal:  mSphere       Date:  2022-02-16       Impact factor: 4.389

Review 2.  Breast Milk, a Source of Beneficial Microbes and Associated Benefits for Infant Health.

Authors:  Katríona E Lyons; C Anthony Ryan; Eugene M Dempsey; R Paul Ross; Catherine Stanton
Journal:  Nutrients       Date:  2020-04-09       Impact factor: 5.717

3.  Optimization of the Microwave Assisted Glycosylamines Synthesis Based on a Statistical Design of Experiments Approach.

Authors:  Jo Sing Julia Tang; Kristin Schade; Lucas Tepper; Sany Chea; Gregor Ziegler; Ruben R Rosencrantz
Journal:  Molecules       Date:  2020-11-04       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.